Resistance Training

1. BioSignal Quick Verdict

• Does it work? Yes — unequivocally, for its core outcomes. Resistance training reliably increases

strength and muscle mass [R4, R5], and national and international guidelines recommend muscle-strengthening activity for all adults [R1, R2]. Its downstream health effects — bone, glycemic control, blood pressure, mood, function in aging — are substantial and, for several, RCT-supported.

• Is it safe? Yes, including for older adults (even with low bone mass, under supervision) [R8]

and children/adolescents (supervised, well-coached) [R12]. Injury rates are low relative to most sports; the main cautions are technique, sensible progression, and blood-pressure/Valsalva awareness in at-risk patients.

• Who benefits most? Nearly everyone — but the largest absolute gains accrue to older adults

(muscle, bone, falls, independence) [R8, R9], people with type 2 diabetes / insulin resistance [R10], and anyone dieting for fat loss who wants to preserve muscle (with adequate protein, see #008).

• Who probably does not need more than the minimum? No one is excluded; even a minimal dose (as

little as ~30–60 min/week) is associated with meaningful risk reduction [R3], so the "right amount" is "at least some, ideally ≥2 days/week."

• Overall confidence: High that RT increases strength, muscle, and bone, and improves glycemic

control and depressive symptoms; Moderate-High for mortality and falls (observational or multi-component); Moderate for blood pressure and quality of life; Limited/Emerging for cognition.

• Evidence stability: High for the core physiological and functional outcomes; Moderate for the

precise dose-response and the magnitude of chronic-disease effects.

• One-sentence bottom line: *Resistance training is one of the most broadly beneficial and best-evidenced

health behaviors there is — it builds strength, muscle, and bone, improves metabolic and mental health, and preserves independence with age — and it is safe and effective across the lifespan when programmed and progressed sensibly.*

• Most common misconception: *That heavy lifting is dangerous for older adults or children, or that it

makes women "bulky."* Supervised RT is safe and beneficial for older adults [R8] and youth [R12], and women do not develop large muscles without deliberate, prolonged, high-volume training.

2. Executive Summary

Resistance training is exercise in which muscles contract against external resistance — free weights, machines, bands, or body weight — with the goal of increasing strength, muscle mass (hypertrophy), power, and function. It is distinct from aerobic ("cardio") training and produces largely complementary benefits; major guidelines recommend both, with muscle-strengthening activity on ≥2 days per week for all adults [R1, R2].

The physiological effects are among the best-established in exercise science. RT reliably increases strength (driven by neural adaptation early and by hypertrophy plus continued neural gains over time) and muscle size, with a graded dose-response to weekly volume for hypertrophy [R4] and a load dependence for maximal strength (heavier loads maximize strength, while hypertrophy can be achieved across a broad range of loads taken close to failure) [R5]. Training to momentary failure is not necessary when weekly volume is matched [R6] — a finding that reframes a great deal of gym dogma.

The health and clinical effects are broad. For bone, high-intensity resistance-and-impact training improved bone mineral density and function even in postmenopausal women with osteopenia/osteoporosis, safely under supervision (the LIFTMOR RCT) [R8]. For metabolism, structured exercise including resistance training lowers HbA1c in type 2 diabetes (≈0.67% in a large meta-analysis) [R10] and improves insulin sensitivity. For blood pressure, dynamic resistance training produces modest reductions [R11]. For mental health, RT significantly reduces depressive symptoms across RCTs [R7]. For aging, RT counters sarcopenia and, as part of exercise programs, reduces falls in community-dwelling older adults [R9]. And large prospective cohorts link muscle-strengthening activity to ~10–17% lower all-cause, cardiovascular, cancer, and diabetes mortality, with much of the benefit at a modest dose (~30–60 min/week) [R3] — an association that is strong and consistent, though observational and therefore interpreted with appropriate caution.

RT is safe across the lifespan. Supervised, well-coached resistance training is safe and beneficial for children and adolescents and does not stunt growth or damage growth plates [R12]; it is safe and especially valuable for older adults [R8]. Common fears — that it is dangerous for elders, harmful for youth, or "bulking" for women — are not supported by the evidence.

BioSignal's overall verdict: resistance training is effective for strength, muscle, bone, metabolic health, and mental health, and safe across the lifespan, with high confidence for its core outcomes; the chronic-disease and mortality associations are strong but observational (moderate-high confidence), and optimal dosing is a matter of refinement, not doubt.

3. Scientific Mechanisms

Mechanical tension and hypertrophy. The principal driver of muscle growth is mechanical tension — force exerted by muscle fibers against load, especially through a full range of motion and near-maximal effort. Tension triggers intracellular signaling (including mTOR pathways) that, with adequate protein and recovery, increases muscle protein synthesis and, over time, myofibrillar accretion (see #008 for the protein side). Volume (hard sets × load × reps) is the summed stimulus and shows a dose-response for size [R4].

Neural adaptation and strength. Early strength gains (first weeks) are largely neural — improved motor-unit recruitment, rate coding, and coordination — which is why beginners get stronger before they visibly grow, and why strength is load-dependent: lifting heavy teaches the nervous system to produce force [R5]. Continued strength reflects both neural refinement and added muscle.

Progressive overload. Adaptation requires a stimulus that exceeds current capacity; systematically increasing load, reps, sets, or difficulty over time (progressive overload) is the central organizing principle of effective programming. Without it, progress plateaus.

Effort and proximity to failure. Recruiting the full motor-unit pool requires high effort — sets taken close to failure. But once weekly volume is sufficient, going to momentary failure adds little and increases fatigue and injury risk [R6]; effort is necessary, absolute failure is optional.

Recovery, DOMS, and detraining. Muscle adapts between sessions; ~48 hours for a trained muscle group is typical, supported by sleep and protein. Delayed-onset muscle soreness (DOMS) reflects unaccustomed eccentric work and is not a measure of growth — soreness and hypertrophy are dissociable. Detraining begins within ~2–3 weeks of stopping; strength is retained longer than it is built, and previously trained muscle regains size quickly ("muscle memory").

Systemic mechanisms. RT increases muscle glucose uptake and insulin sensitivity (more muscle = a larger glucose sink; contraction recruits GLUT4 independent of insulin) [R10], imposes osteogenic loading on bone [R8], and exerts neuroendocrine and psychological effects relevant to mood [R7].

4. Body Systems

• Musculoskeletal (primary): strength, muscle mass, power, and bone density [R4, R5, R8].
• Metabolic/endocrine: improved insulin sensitivity and glycemic control; body-composition effects

[R10].

• Cardiovascular: modest blood-pressure reduction; complementary to aerobic training [R11].
• Nervous system / neuromuscular: motor-unit recruitment, motor learning, balance and coordination

(contributing to falls reduction) [R9].

• Mental health / CNS: reduced depressive symptoms; anxiety and quality-of-life benefits [R7].
• Functional/geriatric: preserved independence, reduced frailty and falls in aging [R8, R9].

5. Major Claims

Each claim: verdict, confidence, evidence summary, supporting studies/references, evidence quality, conflicting evidence, limitations, remaining unknowns, clinical interpretation, and what would change our mind. Verdicts: Supported · Mixed · Not Established · Contradicted.

Claim 1 — "Resistance training increases strength."

• Verdict: Supported. Confidence: High.
• Evidence: Extensive RCT literature; load dependence quantified in meta-analysis (heavier loads

maximize maximal strength) [R5]; endorsed by activity guidelines [R1, R2].

• Evidence quality: High (numerous RCTs, consistent, mechanistically grounded).
• Would change our mind: Nothing plausible — this is among the most robust findings in the field.

Claim 2 — "Resistance training increases muscle mass."

• Verdict: Supported. Confidence: High.
• Evidence: Dose-response meta-analysis: greater weekly volume → greater hypertrophy [R4]; hypertrophy

achievable across a wide load range taken near failure [R5].

• Limitations/unknowns: Individual response varies; the upper end of useful volume and the exact optimum

per person remain debated.

Claim 3 — "Resistance training improves healthy aging and reduces frailty."

• Verdict: Supported. Confidence: High.
• Evidence: RT counters sarcopenia; improves strength/function in older adults, including bone and

falls-relevant outcomes [R8, R9]; guideline-recommended for older adults [R1, R2].

• Clinical interpretation: A first-line intervention for maintaining independence with age.

Claim 4 — "Resistance training reduces all-cause mortality."

• Verdict: Supported (observational). Confidence: Moderate-High.
• Evidence: Meta-analysis of prospective cohorts: muscle-strengthening activity associated with **~10–17%

lower** all-cause, cardiovascular, cancer, and diabetes mortality; J-shaped, with much benefit at ~30–60 min/week [R3].

• Conflicting evidence/limitations: Observational — residual confounding and reverse causation cannot

be excluded; self-reported activity; the very-high-dose end is less certain (J-shape).

• Would change our mind: Large trials (or negative-control/Mendelian-randomization analyses) contradicting

the cohort associations.

Claim 5 — "Resistance training improves insulin sensitivity and type 2 diabetes (HbA1c)."

• Verdict: Supported. Confidence: Moderate-High.
• Evidence: Structured exercise (including resistance and combined training) lowered HbA1c by ≈0.67%

in a large meta-analysis of RCTs in T2D [R10]; RT increases muscle glucose disposal.

• Limitations: Much evidence pools resistance with aerobic/combined; RT-only effect sizes vary; adherence

matters. Clinical interpretation: an evidence-based adjunct to T2D management, not a replacement for medical care.

Claim 6 — "Resistance training improves cardiovascular health / lowers blood pressure."

• Verdict: Supported (modest). Confidence: Moderate.
• Evidence: Dynamic resistance training lowered systolic and diastolic BP in a large meta-analysis [R11].
• Limitations: Effect sizes are modest and smaller/variable vs. aerobic training; isometric protocols may

differ. Clinical interpretation: complementary to aerobic exercise and medical therapy for BP.

Claim 7 — "Resistance training increases bone density."

• Verdict: Supported. Confidence: Moderate-High.
• Evidence: The LIFTMOR RCT — high-intensity resistance-and-impact training improved lumbar-spine and

femoral-neck BMD and function in postmenopausal women with low bone mass, without adverse events under supervision [R8].

• Limitations: Best evidence is for high-intensity/impact protocols and specific populations;

supervision matters for safety in osteoporosis. Clinical interpretation: an adjunct to osteoporosis care (with calcium/vitamin D, see #002), not a stand-alone cure.

Claim 8 — "Resistance training reduces falls."

• Verdict: Supported (as part of exercise programs). Confidence: Moderate.
• Evidence: Cochrane review: exercise reduces falls in community-dwelling older adults; programs combining

balance + functional + resistance exercise are effective [R9].

• Limitations: Falls reduction is driven by multi-component programs; RT alone is one contributor,

most effective when paired with balance training.

Claim 9 — "Resistance training improves mental health (depression/anxiety)."

• Verdict: Supported (depression). Confidence: Moderate-High.
• Evidence: Meta-analysis/meta-regression of RCTs: RT significantly reduced depressive symptoms,

irrespective of health status or strength gains [R7]. Anxiety benefits are also reported (graded lower — flag for a dedicated anxiety reference).

• Limitations: Heterogeneous measures; blinding is difficult in exercise trials. **Clinical

interpretation:** a reasonable adjunct for depressive symptoms, not a replacement for indicated treatment.

Claim 10 — "Resistance training improves cognition."

• Verdict: Not Established / Emerging. Confidence: Limited. Signals exist (executive function in

older adults), but the evidence is mixed and less mature than for mood. (Flag for reviewer: attach a dedicated cognition reference or keep explicitly under-evidenced.)

Claim 11 — "Training to failure is necessary."

• Verdict: Not Established / Contradicted. Confidence: Moderate-High. When weekly **volume is

equated, training to momentary failure confers no consistent added benefit** for strength and little for hypertrophy, while adding fatigue and injury risk [R6]. Effort matters; absolute failure is optional.

Claim 12 — "More volume always produces more growth."

• Verdict: Mixed / Contradicted (as absolute). Confidence: Moderate. Hypertrophy shows a

dose-response to weekly volume [R4], but the relationship is not unlimited — returns diminish and excessive volume risks under-recovery. "More, up to a point," not "more without limit."

Claim 13 — "Machines are inferior / free weights are always superior."

• Verdict: Not Established. Confidence: Moderate. Both build strength and muscle effectively; each

has trade-offs (free weights: stability/skill transfer; machines: control, safety, isolation). The best choice is context- and person-dependent. (Flag for reviewer: attach a machines-vs-free-weights reference.)

Claim 14 — "Children should not lift / lifting stunts growth."

• Verdict: Contradicted. Confidence: High. The 2014 International Consensus concludes supervised,

age-appropriate youth resistance training is safe and effective and does not harm growth plates or stunt growth; injury risk is low with proper coaching [R12].

Claim 15 — "Older adults should avoid heavy lifting."

• Verdict: Contradicted. Confidence: High. Supervised high-intensity resistance (and impact)

training is safe and beneficial for older adults, including those with low bone mass [R8].

Claim 16 — "Cardio is better than lifting" / "Soreness equals growth" / "Muscle confusion is necessary."

• Verdicts: Cardio vs lifting — Mixed/false dichotomy (different, complementary benefits; guidelines

recommend both) [R1, R2]. Soreness = growth — Contradicted (DOMS is not a hypertrophy signal). Muscle confusion — Contradicted (progressive overload, not constant novelty, drives adaptation). (The latter two are mechanistic/consensus; flag for dedicated references.)

6. Question Resolution (selected)

• How much is enough? ≥2 days/week muscle-strengthening for all adults [R1, R2]; even ~30–60 min/week is

associated with meaningful mortality reduction [R3].

• How many sets/reps/load? Hypertrophy: ~10+ hard sets/muscle/week across a broad rep range near effort

[R4, R5]; strength: heavier loads, fewer reps [R5].

• Train to failure? Not required when volume is adequate [R6].
• Progressive overload? Essential — the core driver of continued adaptation.
• Recovery? ~48 h/muscle; protein (#008) and sleep support adaptation.
• Longevity/mortality? Associated with lower mortality (observational) [R3].
• Insulin/HbA1c/BP/bone/falls/mood? Improves glycemic control [R10], modestly lowers BP [R11], increases

BMD [R8], contributes to falls reduction [R9], reduces depressive symptoms [R7].

• Weight loss / muscle preservation? Preserves lean mass during energy restriction (with adequate protein,

#008); aids body composition.

• How fast are gains lost? Detraining begins ~2–3 weeks; retrained faster than first built.
• Beginners? Rapid early gains (neural + newbie hypertrophy).
• Older adults heavy? Yes, supervised [R8]. Children? Yes, supervised; no growth harm [R12].
• Free weights vs machines / compound vs isolation / min effective dose / max useful dose? Both tools

work (consensus — dedicated reference pending); compounds are time-efficient; minimum effective dose is low [R3]; useful volume has diminishing returns [R4].

7. Confidence Justification

• High: strength [R5], muscle [R4], bone [R8], depressive-symptom reduction [R7], safety in youth [R12]

and older adults [R8] — all RCT- or consensus-backed.

• Moderate-High: mortality [R3] and glycemic control [R10] — strong and consistent, but partly

observational (mortality) or pooled with other exercise (HbA1c).

• Moderate: blood pressure [R11] (modest effect), falls [R9] (multi-component), quality of life.
• Limited/Emerging: cognition — signals present, evidence immature.
• Why not higher where capped: observational designs (mortality), pooling of RT with aerobic (HbA1c),

multi-component programs (falls), and modest effect sizes (BP) each warrant calibrated confidence.

8. Remaining Unknowns

• The precise individual optimum for volume, frequency, and intensity, and how it shifts with training

status, age, and goals.

• The isolated contribution of RT (vs. combined training) to HbA1c, BP, and mortality.
• Causal confirmation of the mortality association beyond cohorts [R3].
• The magnitude and durability of cognitive benefits.
• Long-term hard fracture outcomes from RT-driven BMD gains [R8].
• Optimal integration of RT with aerobic training for competing/complementary adaptations.

9. Clinical Context (Populations)

• Healthy adults: ≥2 days/week; progress load over time [R1, R2].
• Beginners: rapid early gains; prioritize technique and consistency; failure unnecessary [R6].
• Intermediate/advanced: manage weekly volume and recovery for continued progress [R4].
• Older adults: supervised RT, including higher intensity, improves strength, bone, and falls risk;

frailty is an indication [R8, R9].

• Women: same programming principles; do not become "bulky" without deliberate high-volume training

over years (physiology/consensus — flag).

• Children/adolescents: safe and beneficial with qualified supervision; no growth-plate harm [R12].
• Pregnancy: generally safe to continue/modify per obstetric guidance; avoid Valsalva/supine late; WHO

addresses activity in pregnancy [R2]. (Flag for reviewer: attach pregnancy-specific RT reference.)

• Type 2 diabetes / obesity: improves glycemic control and body composition; adjunct to medical care

[R10].

• Osteoporosis: supervised, appropriately progressed high-intensity/impact protocols improve BMD [R8];

avoid unsupervised maximal spinal loading in severe disease.

• Cardiovascular disease: beneficial with individualized programming; screen for unstable disease and

uncontrolled hypertension; teach breathing to limit Valsalva BP spikes.

• Cancer survivors / rehabilitation: RT improves strength, function, and quality of life; program with

the treating team. (Flag for reviewer: attach oncology-rehab reference.)

10. Safety

Resistance training is safe for the large majority of people, with injury rates lower than most recreational sports — particularly when supervised and sensibly progressed. Safety is about screening, technique, and progression, not exclusion.

• Absolute contraindications (to vigorous RT until stabilized/cleared): unstable or decompensated

cardiac disease (unstable angina, uncontrolled arrhythmia, decompensated heart failure), acute coronary/aortic events, severe uncontrolled hypertension, acute musculoskeletal injury, or an acute medical illness. These require medical stabilization and clearance first.

• Relative contraindications / individualize: controlled cardiovascular disease, moderate

hypertension, severe osteoporosis (avoid unsupervised maximal spinal flexion/loading), hernia, recent surgery, retinopathy or aneurysm risk, and advanced pregnancy — proceed with tailored programming and, where relevant, professional supervision.

• Blood pressure & the Valsalva maneuver: heavy lifting with breath-holding transiently raises blood

pressure; teach exhale-on-exertion breathing and avoid maximal Valsalva in hypertensive, cardiac, aneurysm, or retinopathy patients.

• Technique & progression: most injuries stem from poor form or advancing load too fast. Prioritize

competent technique, controlled range of motion, and progressive (not abrupt) overload.

• Spotting & equipment: use spotters or safety pins/racks for heavy free-weight lifts (bench, squat);

machines can reduce the need for a spotter and are a reasonable option for novices and clinical populations.

• Back pain: RT (including appropriately loaded, well-coached lifting) is generally beneficial, not

harmful, for most non-specific low-back pain; avoid painful maximal loading during acute flares and progress gradually.

• Older adults: safe and beneficial, including higher-intensity work under supervision [R8]; screen for

balance, cardiac, and bone status and individualize.

• Youth: safe with qualified coaching; emphasize technique over maximal loads; no growth harm [R12].
• Medical clearance ("screen, don't gatekeep"): most healthy people can begin light-to-moderate RT

without formal clearance; obtain medical evaluation for known cardiovascular/metabolic/renal disease, symptoms (chest pain, syncope), or before vigorous training in higher-risk individuals, consistent with pre-participation screening frameworks.

11. Practical Programming (Educational — Not Individual Prescription)

Programming is educational, not an individual prescription. Clinical populations should train under appropriate professional and medical guidance.

12. Special Topics (concise)

• Progressive overload / mechanical tension: the two central drivers of adaptation (§3).
• Volume / intensity / frequency: volume is the main hypertrophy lever [R4]; load drives max strength

[R5]; frequency mainly distributes volume.

• Hypertrophy vs strength vs power: overlapping but distinct adaptations (size vs force vs rate of force).
• Neural adaptation / motor learning: dominate early strength gains (§3).
• DOMS: soreness ≠ growth; not a programming target.
• Detraining: losses begin ~2–3 weeks; "muscle memory" speeds regain.
• Tempo / range of motion: full ROM generally favored for hypertrophy and function; extreme tempos are

optional tools.

• Split routines vs full-body: both work if weekly volume and recovery are met.

13. Programming Comparison Table (goal → emphasis)

14. Common Myths

• "Lifting stunts growth." Contradicted — supervised youth RT is safe; no growth-plate harm [R12].
• "Women get bulky." Contradicted — large muscle gain requires deliberate, prolonged high-volume training

(physiology/consensus).

• "Machines don't work." Contradicted — machines build strength and muscle effectively (consensus — dedicated reference pending).
• "More soreness means more growth." Contradicted — DOMS is not a hypertrophy signal.
• "Train to failure every set." Contradicted — unnecessary when volume is adequate [R6].
• "Six days per week is required." Contradicted — ≥2 days/week meets guidelines; benefit starts even lower

[R1, R3].

• "Older adults shouldn't lift." Contradicted — safe and beneficial, including heavier loads [R8].
• "Cardio is enough." Incomplete — aerobic and resistance training confer different, complementary

benefits; guidelines recommend both [R1, R2].

• "Muscle confusion builds muscle." Contradicted — progressive overload, not constant novelty, drives

adaptation.

• "Light weights only tone." Misleading — "toning" is muscle + fat loss; hypertrophy occurs across loads

taken near effort [R5].

15. Related Signals

Cross-referenced records and concepts: Protein Intake (#008 — fuels adaptation and muscle retention), Collagen (#009 — an incomplete protein; not a substitute for complete protein around training), Creatine (well-evidenced ergogenic adjunct), Whey Protein (#005 — convenient complete protein), Sleep (recovery and adaptation), Vitamin D (#002 — muscle/bone), Magnesium (#003 — muscle function), Walking / Aerobic Training (complementary), Hydration / Electrolytes, Healthy Aging / Sarcopenia, and Weight Loss (lean-mass preservation).

18. Future Research Priorities

• Causal confirmation of the mortality association [R3] (e.g., Mendelian randomization, long trials).
• RT-isolated effect sizes for HbA1c, BP, and cardiovascular events, distinct from combined training.
• Maturation of the cognition evidence, with functional endpoints.
• Hard fracture outcomes from RT-driven BMD gains [R8].
• Personalized dose-response models across age, sex, and training status.
• Optimal concurrent (RT + aerobic) programming to minimize interference.

20. Complete Verified Reference List

Each entry was verified to source during authoring. PMIDs are included where confirmed; DOIs where confirmed. This is a curated landmark tier, not an exhaustive bibliography; the reviewer checklist requires attaching dedicated references for flagged claims.

• [R1] Piercy KL, Troiano RP, Ballard RM, et al. The Physical Activity Guidelines for Americans. JAMA.

2018;320(19):2020-2028. doi:10.1001/jama.2018.14854. PMID: 30418471. (Muscle-strengthening ≥2 days/week.)

• [R2] Bull FC, Al-Ansari SS, Biddle S, et al. *World Health Organization 2020 guidelines on physical

activity and sedentary behaviour.* Br J Sports Med. 2020;54(24):1451-1462. doi:10.1136/bjsports-2020-102955. PMID: 33239350.

• [R3] Momma H, Kawakami R, Honda T, Sawada SS. *Muscle-strengthening activities are associated with lower

risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies.* Br J Sports Med. 2022;56(13):755-763. doi:10.1136/bjsports-2021-105061. PMID: 35228201.

• [R4] Schoenfeld BJ, Ogborn D, Krieger JW. *Dose-response relationship between weekly resistance training

volume and increases in muscle mass: a systematic review and meta-analysis. J Sports Sci. 2017;35(11):1073-1082. doi:10.1080/02640414.2016.1210197. PMID: 27433992. (Hypertrophy dose-response; ~10+ weekly sets.)*

• [R5] Schoenfeld BJ, Grgic J, Ogborn D, Krieger JW. *Strength and hypertrophy adaptations between low- vs.

high-load resistance training: a systematic review and meta-analysis. J Strength Cond Res. 2017;31(12):3508-3523. doi:10.1519/JSC.0000000000002200. PMID: 28834797. (Heavy loads for maximal strength; hypertrophy across a broad load range.)*

• [R6] Vieira AF, Umpierre D, Teodoro JL, et al. *Effects of resistance training performed to failure or

not to failure on muscle strength, hypertrophy, and power output: a systematic review with meta-analysis.* J Strength Cond Res. 2021;35(4):1165-1175. doi:10.1519/JSC.0000000000003936. PMID: 33555822.

• [R7] Gordon BR, McDowell CP, Hallgren M, Meyer JD, Lyons M, Herring MP. *Association of efficacy of

resistance exercise training with depressive symptoms: meta-analysis and meta-regression analysis of randomized clinical trials.* JAMA Psychiatry. 2018;75(6):566-576. doi:10.1001/jamapsychiatry.2018.0572. PMID: 29800984.

• [R8] Watson SL, Weeks BK, Weis LJ, Harding AT, Horan SA, Beck BR. *High-Intensity Resistance and Impact

Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial.* J Bone Miner Res. 2018;33(2):211-220. doi:10.1002/jbmr.3284. PMID: 28975661.

• [R9] Sherrington C, Fairhall NJ, Wallbank GK, et al. *Exercise for preventing falls in older people

living in the community.* Cochrane Database Syst Rev. 2019;(1):CD012424. doi:10.1002/14651858.CD012424.pub2. PMID: 30703272.

• [R10] Umpierre D, Ribeiro PA, Kramer CK, et al. *Physical activity advice only or structured exercise

training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2011;305(17):1790-1799. doi:10.1001/jama.2011.576. PMID: 21540423. (Structured exercise ↓ HbA1c ≈0.67%.)*

• [R11] Cornelissen VA, Smart NA. *Exercise training for blood pressure: a systematic review and

meta-analysis.* J Am Heart Assoc. 2013;2(1):e004473. doi:10.1161/JAHA.112.004473. PMID: 23525435.

• [R12] Lloyd RS, Faigenbaum AD, Stone MH, et al. *Position statement on youth resistance training: the

2014 International Consensus.* Br J Sports Med. 2014;48(7):498-505. doi:10.1136/bjsports-2013-092952. PMID: 24055781.

Clickable identifiers: R1 US Physical Activity Guidelines · R2 WHO 2020 guidelines · R3 muscle-strengthening & mortality · R4 volume dose-response · R5 low vs high load · R6 training to failure · R7 depression (JAMA Psychiatry) · R8 LIFTMOR bone RCT · R9 Cochrane falls prevention · R10 exercise & HbA1c (T2D) · R11 exercise & blood pressure · R12 youth resistance training consensus

21. Suggested Version Number

Version 1.0 (review-hardened) — initial Gold Standard Clinical Monograph draft entering the Editorial Workflow (scientific + medical review), incorporating the senior editorial review: a dedicated Safety section was added (absolute/relative contraindications, Valsalva/BP, technique, spotting, back pain, medical clearance) to match the #008/#009 spine and the brief's safety requirement, and the two pending PMIDs (R4 27433992, R5 28834797) were verified and attached. Semantic-versioning note: attaching the flagged dedicated references (anxiety, cognition, machines-vs-free-weights, hypertrophy physiology, pregnancy, cancer-rehab) would be a 1.1 (minor) update; any change to a verdict or a headline confidence rating (e.g., if a causal mortality trial altered the mortality claim) would be a 2.0 (major) update.